Setidegrasib in Advanced Non–Small-Cell Lung Cancer and Pancreatic Cancer

Data ReadoutSetidegrasibNeutral

AI Analysis

Summary

New England Journal of Medicine publishes results of setidegrasib in advanced non-small-cell lung cancer and pancreatic cancer. The article provides clinical trial data on the drug candidate for these cancer indications.

Clinical Trial Data

Importance:5/10

Sentiment:

0.00

oncologylung cancerpancreatic cancerclinical trialpublished research

Related Companies

$SHWZ $ADVB

Read the original article

Published by New England Journal of Medicine on March 25, 2026 3:45 AM

Read Original